Fundraising FoxBiotech Startups
11,114 companies tagged Biotech, with their investors and founders.
Abeona Therapeutics develops and commercializes cell and gene therapies for rare genetic diseases, including ZEVASKYN, an FDA-approved autologous gene-modified cell therapy for wounds in recessive dystrophic epidermolysis bullosa, along with a portfolio of adeno-associated virus-based gene therapies for ophthalmic disorders.
0 investors
0 investors
PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.
0 investors
Plexiform Bio is developing non-invasive treatments for retinal vascular diseases, which are currently treated primarily through injections into the eye. The company aims to offer alternatives to frequent, uncomfortable eye injections for patients with retinal conditions that cause blurred vision.
0 investors
0 investors
Pluristyx develops induced pluripotent stem cell (iPSC) technologies, including non-modified and genetically engineered cell lines, proprietary gene edits, and reprogramming platforms, along with related services. It provides these products and end-to-end development support to companies building cell and stem cell therapies.
0 investors
0 investors
Cerenome operates an integrated central nervous system (CNS) oncology platform that combines precision diagnostics, targeted radiotherapeutics, and clinical data to improve how CNS cancers are detected, treated, and monitored. Evolving from work begun at Plus Therapeutics in 2020, it serves patients with CNS cancers.
0 investors
0 investors
0 investors
0 investors
PNP Therapeutics is a clinical-stage biopharmaceutical company developing Gedeptin, a platform technology for cancer treatment that programs tumors to generate their own chemotherapy through a patented enzyme and prodrug system. The company targets patients with solid tumors including prostate, breast, colon, lung, brain, melanoma, pancreas, ovarian, and kidney cancers.
0 investors
POET is the world leader in bioethanol production, using agricultural resources to create renewable bioproducts including bioethanol, high-quality food and feed products, purified alcohol, captured carbon dioxide, corn oil-based asphalt solutions, engineering and construction services, and logistics support.
0 investors
0 investors
Polybiomics develops a live cell analysis platform that measures multiple phenotypes and functions of cells simultaneously and continuously without disrupting them or their 3D environments. The system combines a bioinstrument, consumable, and the PolyData analytics engine with AI to interpret multimodal datasets for research, pharmaceutical, biomanufacturing, and clinical workflows.
0 investors
0 investors
0 investors
PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors